Skip to main content
main-content

28.04.2018 | Original Article

The impact of grape proanthocyanidin extract on dexamethasone-induced osteoporosis and electrolyte imbalance

Zeitschrift:
Comparative Clinical Pathology
Autoren:
Nabil A. Hasona, Abdullah Morsi, Abdullah Ali Alghabban

Abstract

To evaluate the effects of osteoporosis induced by dexamethasone (DEX) and assess the possible anti-osteoporotic effect of grape seed proanthocyanidin extract (GSPE) on bone tissue of female albino rats. Thirty-two female albino rats divided into four groups: normal, DEX control, orally treated with GSPE (400 mg/kg) 7 days before DEX-injection, and orally treated with GSPE (400 mg/kg) after DEX-injection for 4 weeks. Animals received 0.1 mg/kg of dexamethasone intramuscularly three times per week for 4 weeks. After 4 weeks, the animals were sacrificed, and blood samples were collected for determination of biochemical investigations. Right, and left femurs were excised for biochemical and histological examination. DEX-induced remarkable elevation in the activities of alkaline phosphatase and acid phosphatase, and level of blood urea nitrogen (BUN) with concomitant declined in electrolyte profile (Na, K, and Ca). Lipid peroxidation marker (MDA) was significantly elevated in DEX-induced animals with concomitant declined in glutathione (GSH) content and superoxide dismutase (SOD) activity. Administration of GSPE significantly alleviates serum activities of alkaline phosphatase and acid phosphatase and blood urea nitrogen (BUN) level. GSPE attenuated DEX-induced oxidative stress and restored the antioxidant defenses. In addition, GSPE improved femur bone histological structure alterations induced by dexamethasone. GSPE possessed antioxidant potentials, and anti-osteoporotic effects against glucocorticoids induced osteoporotic rats by the maintenance of calcium homeostasis and scavenging of the free radicals which in turn induced the lipid peroxidation. Thus, GSPE may be a candidate as an anti-osteoporotic agent.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der Fachzeitschriften, inklusive eines Print-Abos.

Literatur
Über diesen Artikel

Neu im Fachgebiet Pathologie

26.06.2018 | Prostatakarzinom | CME | Ausgabe 4/2018

CME: Neuroendokrines Prostatakarzinom

19.06.2018 | Schwerpunkt: Pathologie und Forschungsbiobanken | Ausgabe 4/2018

Der Aufbau und Betrieb einer Zentralen Biomaterialbank

Die ZeBanC der Charité Berlin

06.06.2018 | Schwerpunkt: Pathologie und Forschungsbiobanken | Ausgabe 4/2018

Biobanking und die Weiterentwicklung der Präzisionsmedizin

23.05.2018 | Schwerpunkt: Pathologie und Forschungsbiobanken | Ausgabe 4/2018

Alle unter einem Dach

Erfolge und Herausforderungen auf dem Weg zu einer zentralisierten Biobank am Beispiel der BMBH